TE1 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Bio-Techne Corp

Watchlist Manager

Watchlist

Price: 63.14 EUR 0.38% Market Closed

Market Cap: €9.9B

B	Bio-Techne Corp F:TE1	US
	Stellantis NV PAR:STLAP	NL
	Co-Diagnostics Inc NASDAQ:CODX	US
	Echo Investment SA F:4I3	PL
	Bio-Techne Corp NASDAQ:TECH	US
S	Schroders PLC F:PYXB	UK
C	CVS Health Corp F:CVS	US
	Eurocell PLC LSE:ECEL	UK
T	Takeda Pharmaceutical Co Ltd SWB:TKD	JP
R	Regenxbio Inc SWB:RB0	US

Profitability Summary

Bio-Techne Corp's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

66%

Strong 3Y Average Gross Margin

67%

Declining Gross Margin

68% > 66%

Healthy Operating Margin

23%

Sustainable 3Y Average Operating Margin

22%

Declining Operating Margin

25% > 23%

Healthy Net Margin

15%

Sustainable 3Y Average Net Margin

13%

Declining Net Margin

22% > 15%

Exceptional Free Cash Flow Margin

22%

Strong 3Y Average Free Cash Flow Margin

19%

Free Cash Flow Margin is Increasing

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.